HOME >> MEDICINE >> NEWS
Scientists discover recipe for life: eating the 'Polymeal' cuts heart disease by 76%

Scientists in this week's Christmas issue of the BMJ have discovered the 'Polymeal', a set of ingredients which cuts the risk of heart (cardiovascular) disease by 76% and significantly increases life expectancy.

Results of dining on the Polymeal were most dramatic for men, who were projected to live on average 6.6 years longer in total than those not eating the meal. Men will also live for nine years longer without succumbing to heart disease, and those that do will suffer it for less years of their lives.

Women eating the Polymeal will also live significantly longer, nearly five years more than women not eating the meal. They will also put off the onset of heart disease for eight years longer.

The Polymeal includes wine, fish, dark chocolate, fruits and vegetables, almonds and garlic, eaten on a daily basis (but four times a week for fish). Scientists reviewed the medical literature on how much each ingredient cuts heart disease, blood pressure or cholesterol levels by varying amounts, (150ml wine daily for instance reduces heart disease by 32%) and worked out the combined effect of the ingredients. They then calculated the potential effect across an ongoing study of American adults.

The findings follow research last year (2003) into a 'Polypill', a combination of drugs taken in one dose which was designed to reduce heart disease by more than 80%. The authors of the Polymeal study were searching for a non-pharmaceutical alternative.

In Western society we are all at risk from the causes of cardiovascular disease, say the authors, and the diseases that accompany it. Following the Polymeal promises to be an effective, non-pharmacological, safe and tasty means to increasing life expectancy and reducing heart disease across the population, they conclude.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
16-Dec-2004


Page: 1

Related medicine news :

1. Scientists replicate hepatitis C virus in laboratory
2. Scientists identify brain regions that decide where we look
3. Scientists uncover new mechanism for the amygdala in fear recognition
4. Scientists identify protein critical to melanoma growth
5. Scientists study fish oil diet in bid to cut heart attack risks
6. Scientists discover enzyme crucial to the transportation of proteins within cells
7. Scientists turn on the gender lens on cardiovascular disease research
8. Scientists stalk PPAR-gamma, find novel cancer connection
9. Scientists align billion-year-old protein with embryonic heart defects
10. Scientists pinpoint flaw, offer new promise for stroke treatment
11. Scientists discover enzyme crucial to HIV replication

Post Your Comments:
(Date:6/20/2013)... Businesses which are failing to be savvy ... up in the tidal wave of competition, warns Australia's leading ... Marketing: 50 Tips Collected from the Top Blogs is ... is to listen to the social media pros. This is ... media since its onset and they, more than most PR ...
(Date:6/20/2013)... June 20, 2013 Millions of Britons ... serious medical conditions because they do not brush their ... and Elgydium toothpaste. , Seven million Britons do not ... hours between brushes, latest data from the British Dental ... people polled by the BDHF also admitted that they ...
(Date:6/20/2013)... HIPAA One aims to ... a HIPAA Security Risk Analysis using the simplest workflow ... the reach of all the HIPAA programs by serving ... Officers, security professionals, and members of the Healthcare interested ... and procedures. The new Web site features expanded ...
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 Paleo Burn ... thousands of people finally sculpt the body they desire with ... other fat loss programs and health food products, Ken Smith ... and finally give consumers an easy, automatic, and permanent solution ... all the details . , After a quick review of ...
(Date:6/19/2013)... A man returning from war is not likely to ... his debut book titled RED DANCER JOURNEY, author Rafael Fraguada pens ... home, looking for the right place and people to mend his ... from the Vietnam War, returns to New York City, he meets ... Wings, a wealthy acquaintance from a tiny Midwest college they both ...
Breaking Medicine News(10 mins):Health News:Social Media Marketing: Casey Gollan's Round-up of Tips from the Top Blogs 2Health News:Social Media Marketing: Casey Gollan's Round-up of Tips from the Top Blogs 3Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 2Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 3Health News:Modern Compliance Solutions Launches a New Web Site Promoting the Industry-Proven, Web-Based HIPAA One Security Solution 2Health News:Paleo Burn Review Released by TotalWellnessCleanse.net 2Health News:Rafael Fragauda’s New Book Underlines Post Traumatic Stress Disorder 2
(Date:6/19/2013)... , June 19, 2013  Echo Therapeutics, ... developing its needle-free Symphony ® CGM System ... today announced the closing of a previously announced ... common stock and the full exercise of the ... at a price to the public of $2.70 ...
(Date:6/19/2013)... , June 19, 2013 Pharmacyclics, Inc. (the ... The New England Journal of Medicine ( ... study evaluating the investigational oral Bruton,s tyrosine kinase (BTK) ... (CLL) or small lymphocytic lymphoma (SLL). Ibrutinib was shown ... CLL or SLL, even in patients who were at ...
(Date:6/19/2013)... BELLEVUE, Wash. , June 19, 2013 ... Provisioning version 4.0, a solution designed to ... to applications and data while supporting their ... release of Provisioning represents a milestone in ... governance and analytics capabilities for health systems. ...
Breaking Medicine Technology:Echo Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Over-Allotment Option by the Underwriter 2Echo Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Over-Allotment Option by the Underwriter 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3
Cached News: